Patterns of creatine kinase release during acute myocardial infarction after nonsurgical reperfusion: comparison with conventional treatment and correlation with infarct size
H Blanke,
D von Hardenberg,
M Cohen,
H Kaiser,
KR Karsch,
J Holt,
H Smith Jr,
and
P Rentrop
Coronary arteriography and biplane ventriculography were performed in 51 patients during the acute (mean of 6.6 hours after onset of symptoms) and chronic (1 to 3 months after admission) phase of myocardial infarction. Twenty-four patients were treated in a conventional manner. In 27 patients, reperfusion was achieved with intracoronary streptokinase after 24 +/- 20 minutes of infusion. Peak creatine kinase and cumulative creatine kinase release were derived from serial creatine kinase measurements. Ejection fraction and the length of the akinetic or dyskinetic segments were calculated in the chronic phase. The time interval between onset of symptoms and peak creatine kinase was significantly shorter for the streptokinase-treated patients as compared with the conventionally treated patients (13.5 +/- 5.3 versus 22.9 +/- 7.4 hours, p = 0.0001). Significant linear correlations were obtained for both streptokinase-treated and control patients, relating: 1) peak creatine kinase value to both length of the noncontracting segment and ejection fraction in the chronic phase, and 2) cumulative creatine kinase release to both length of the noncontracting segment and ejection fraction in the chronic phase. Patients treated with streptokinase experienced a relatively greater release of enzyme for a given infarct size as compared with those treated in a conventional manner. The difference in enzyme release between the two groups increased as infarct size increased. These observations may be explained by enhanced washout of enzyme from the infarct zone, secondary to reperfusion after intracoronary streptokinase therapy.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
H. Thiele, M. J.E. Kappl, S. Conradi, J. Niebauer, R. Hambrecht, and G. Schuler
Reproducibility of Chronic and Acute Infarct Size Measurement by Delayed Enhancement-Magnetic Resonance Imaging
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8):
1641 - 1645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Solomon, R. J. Glynn, S. Greaves, U. Ajani, J.-L. Rouleau, F. Menapace, J. M. O. Arnold, C. Hennekens, and M. A. Pfeffer
Recovery of Ventricular Function after Myocardial Infarction in the Reperfusion Era: The Healing and Early Afterload Reducing Therapy Study
Ann Intern Med,
March 20, 2001;
134(6):
451 - 458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Rentrop
Thrombi in Acute Coronary Syndromes : Revisited and Revised
Circulation,
April 4, 2000;
101(13):
1619 - 1626.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Matetzky, D. Freimark, P. Chouraqui, I. Novikov, O. Agranat, B. Rabinowitz, E. Kaplinsky, and H. Hod
The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion
J. Am. Coll. Cardiol.,
November 1, 1998;
32(5):
1326 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Silber, M. J. Hausmann, A. Katz, H. Gilutz, N. Zucker, and I. Ovsyshcher
Short- and Long-Term Comparative Study of Anistreplase Versus Streptokinase in Acute Myocardial Infarction
Angiology,
July 1, 1992;
43(7):
572 - 577.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ovsyshcher, H. Silber, M.I. Hausman, G. Margolis, and M. Gueron
Improved Left Ventricular Function in Myocardial Infarction Following Intravenous Thrombolytic Therapy with Acylated Plasminogen Activator
Angiology,
February 1, 1990;
41(2):
133 - 138.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. LEE and L. GOLDMAN
Serum Enzyme Assays in the Diagnosis of Acute Myocardial InfarctionRecommendations Based on a Quantitative Analysis
Ann Intern Med,
August 1, 1986;
105(2):
221 - 233.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Wei, J. E. Markis, M. Malagold, and W. Grossman
Time Course of Serum Cardiac Enzymes After Intracoronary Thrombolytic Therapy: Creatine Kinase, Creatine Kinase MB Isozyme, Lactate Dehydrogenase, and Serum Glutamic-Oxaloacetic Transaminase
Arch Intern Med,
September 1, 1985;
145(9):
1596 - 1600.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Choi, R. J. Kim, G. Gubernikoff, J. D. Vargas, M. Parker, and R. M. Judd
Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function
Circulation,
September 4, 2001;
104(10):
1101 - 1107.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|